Krebs, S., O’Donoghue, J. A., Biegel, E., Beattie, B. J., Reidy, D., Lyashchenko, S. K., . . . Pandit-Taskar, N. (2020). Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging.
Chicago Stili AlıntıKrebs, Simone, et al. "Comparison of (68)Ga-DOTA-JR11 PET/CT With Dosimetric (177)Lu-satoreotide Tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in Patients With Metastatic Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy." Eur J Nucl Med Mol Imaging 2020.
MLA AlıntıKrebs, Simone, et al. "Comparison of (68)Ga-DOTA-JR11 PET/CT With Dosimetric (177)Lu-satoreotide Tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in Patients With Metastatic Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy." Eur J Nucl Med Mol Imaging 2020.